LifeSci Acquisition II Corp.
Status: Closed Deal
U=S
| IPO Proceeds, $M | $80.09M |
|---|---|
| IPO Date | Nov 20, 2020 |
| CEO | Andrew McDonald, Ph.D. |
| Left Lead | LifeSci Capital |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | US/Canada |
| Target Company | Science 37 |
| Deal Announced | May 7, 2021 |
| Deal Size, $M | $1,050.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Oct 4, 2021 |
| Amendment Vote | TBD |
| Closing Date | Oct 7, 2021 |
Formerly LSAQ
SNCE
| Price | 5.75 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.